---
reference_id: "PMID:41205594"
title: "Integrated immune, hormonal, and transcriptomic profiling reveals sex-specific dysregulation in long COVID patients with ME/CFS."
authors:
- Shahbaz S
- Osman M
- Syed H
- Mason A
- Rosychuk RJ
- Cohen Tervaert JW
- Elahi S
journal: Cell Rep Med
year: '2025'
doi: 10.1016/j.xcrm.2025.102449
content_type: abstract_only
---

# Integrated immune, hormonal, and transcriptomic profiling reveals sex-specific dysregulation in long COVID patients with ME/CFS.
**Authors:** Shahbaz S, Osman M, Syed H, Mason A, Rosychuk RJ, Cohen Tervaert JW, Elahi S
**Journal:** Cell Rep Med (2025)
**DOI:** [10.1016/j.xcrm.2025.102449](https://doi.org/10.1016/j.xcrm.2025.102449)

## Content

1. Cell Rep Med. 2025 Nov 18;6(11):102449. doi: 10.1016/j.xcrm.2025.102449. Epub 
2025 Nov 7.

Integrated immune, hormonal, and transcriptomic profiling reveals sex-specific 
dysregulation in long COVID patients with ME/CFS.

Shahbaz S(1), Osman M(2), Syed H(3), Mason A(3), Rosychuk RJ(4), Cohen Tervaert 
JW(5), Elahi S(6).

Author information:
(1)Mike Petryk School of Dentistry, Division of Foundational Sciences, 
University of Alberta, Edmonton, AB T6G 2E1, Canada.
(2)Department of Medicine, Division of Rheumatology, University of Alberta, 
Edmonton, AB T6G 2E1, Canada; Li Ka Shing Institute of Virology, University of 
Alberta, Edmonton, AB T6G 2E1, Canada; Women and Children Health Research 
Institute, University of Alberta, Edmonton, AB T6G 2E1, Canada; Cancer Research 
Institute of Northern Alberta, University of Alberta, Edmonton, AB T6G 2E1, 
Canada.
(3)Department of Medicine, Division of Gastroenterology, University of Alberta, 
Edmonton, AB T6G 2E1, Canada.
(4)Department of Pediatrics, Division of Infectious Disease, University of 
Alberta, Edmonton, AB T6G 2E1, Canada.
(5)Department of Medicine, Division of Rheumatology, University of Alberta, 
Edmonton, AB T6G 2E1, Canada.
(6)Mike Petryk School of Dentistry, Division of Foundational Sciences, 
University of Alberta, Edmonton, AB T6G 2E1, Canada; Li Ka Shing Institute of 
Virology, University of Alberta, Edmonton, AB T6G 2E1, Canada; Women and 
Children Health Research Institute, University of Alberta, Edmonton, AB T6G 2E1, 
Canada; Cancer Research Institute of Northern Alberta, University of Alberta, 
Edmonton, AB T6G 2E1, Canada; Glycomics Institute of Alberta, University of 
Alberta, Edmonton, AB T6G 2E1, Canada; Alberta Transplant Institute, Faculty of 
Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2E1, Canada. 
Electronic address: elahi@ualberta.ca.

Long COVID (LC) manifests with sex-specific differences, particularly in those 
with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Our study 
reveals that female LC patients (LCF) with ME/CFS show a shift toward 
myelopoiesis, reduced lymphocytes, increased neutrophils/monocytes, and depleted 
regulatory T cells-suggesting persistent immune activation. Elevated CD71+ 
erythroid cells and disrupted erythropoiesis contribute to fatigue and tissue 
damage in LCF. Cytokine profiling indicates a stronger pro-inflammatory response 
in LCF compared to males (LCM), along with markers of gut barrier dysfunction. 
Hormonal analysis shows reduced testosterone in LCF and estradiol in LCM. 
Transcriptomic data reveal neuroinflammatory signatures in LCF, potentially 
explaining cognitive symptoms. We also identify biomarkers that distinguish LCF 
from LCM and correlate with sex-specific clinical symptoms. Overall, LC with 
ME/CFS is characterized by sex-specific immune, hormonal, and transcriptional 
alterations, with females exhibiting more severe inflammation. These insights 
underscore the need for sex-tailored interventions, including consideration of 
hormone replacement therapy.

Copyright Â© 2025 The Author(s). Published by Elsevier Inc. All rights reserved.

DOI: 10.1016/j.xcrm.2025.102449
PMCID: PMC12711683
PMID: 41205594 [Indexed for MEDLINE]

Conflict of interest statement: Declaration of interests The authors declare no 
competing interests.